This compound is primarily utilized in pharmaceutical research and development as a key intermediate in the synthesis of various biologically active molecules. Its structural framework is particularly valuable in the creation of kinase inhibitors, which are essential in targeting specific enzymes involved in cellular signaling pathways. These inhibitors have potential applications in treating diseases such as cancer, where abnormal kinase activity plays a critical role. Additionally, the compound's unique chemical properties make it a candidate for further exploration in the design of novel therapeutic agents, particularly in the fields of oncology and inflammatory disorders. Its trifluoromethyl and chloro groups contribute to its reactivity and binding affinity, enhancing its utility in drug discovery processes.